Alkermes plc (ALKS)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$45.82
+0.27%
Mkt Cap $7.61B
Analyst Ratings
Buy
16
Hold
2
Sell
1
Price Target (31 analysts)
$58.83
Range $50.00 – $65.00
Implied Upside
+28.4%
Consensus $58.83 vs current $45.82